Helping patients and families make informed decisions about dementia therapies
Official title: Helping Patients, Families, and Clinicians Make Shared Decisions about Therapies for Dementia
Funded at University of Colorado Denver · NIH-10949237 · Data updated 2026-11-12
This study is creating a helpful guide for patients, families, and doctors to make better choices about dementia treatments, especially a new drug called Lecanemab-IRMB, by understanding what people need to know about the benefits and risks of these options.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | September 15, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $234,000 |
| NIH project number | 1R21AG088955-01 |
| Project ID | NIH-10949237 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include patients diagnosed with Alzheimer's disease and their caregivers who are considering treatment options.
✕Less likely to help
Patients who are not diagnosed with Alzheimer's disease or those who are not considering any dementia therapies may not benefit from this research.
What this research studies
This research focuses on developing a patient decision aid to assist patients, families, and clinicians in making informed choices about dementia therapies, particularly the newly approved drug Lecanemab-IRMB. The project will involve a needs assessment to understand the challenges faced in discussing treatment options and will utilize a user-centered approach to create effective communication tools. By facilitating shared decision-making, the research aims to ensure that patients and families are fully aware of the potential benefits and risks associated with dementia treatments.
Why it matters
Potential benefit: If successful, this research could empower patients and families to make better-informed decisions regarding dementia therapies, leading to improved satisfaction and outcomes.
How similar studies have gone: Previous research has shown that decision aids can significantly improve patient understanding and satisfaction in treatment decision-making, indicating a promising approach.
Where this research is happening
-
University of Colorado Denver
Aurora, United States Active
Researchers
- Principal investigator: Matlock, Daniel D — University of Colorado Denver
- Study coordinator: Matlock, Daniel D
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.